This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Scripps Research Institute. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eleanor Bashian and T-Cell Activation Innovation.
Introduction
Eleanor Bashian is an inventor associated with Scripps Research Institute in Laguna Niguel, California. Her work includes an invention aimed at enhancing T-cell activation and supporting immune responses.
Latest Patents
Bashian is associated with 1 patent, titled “Disruption of CD28-Sialoside Ligand Complexes to Enhance T Cell Activation.” The invention describes methods that use a targeting agent linked to a sialidase enzyme, or an enzymatically active fragment, to promote T-cell activation and expansion. It also describes therapeutic conjugates, including combinations of sialidase with a T-cell-targeting antibody, such as an anti-PD1 antibody.
Career Highlights
The patent reflects research into approaches for modulating T-cell activity. Its proposed methods and conjugates are intended to stimulate T-cell immune responses.
Collaborations
Landon J. Edgar and Andrew J. Thompson are identified as Bashian’s coworkers in connection with this research.
Conclusion
Eleanor Bashian’s patent describes an enzyme-targeting approach to enhancing T-cell activation, developed in association with Scripps Research Institute.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile